Tag: Pharmaceuticals
Business & Industry
Eli Lilly Returns to Infectious Disease with $3.8 Billion Acquisition Strategy
After a seven-year absence from the sector, Eli Lilly is returning to the field through a trio of corporate purchases valued at more than...
Business & Industry
Bristol Myers Squibb Integrates AI to Advance Manufacturing Quality Systems
Bristol Myers Squibb has entered into a strategic agreement with Anthropic to deploy its Claude platform across global operations. This initiative moves beyond standard...
Business & Industry
Angelini Pharma Expands US Presence with Catalyst Pharmaceuticals Acquisition
Angelini Pharma has finalized a definitive agreement to acquire Catalyst Pharmaceuticals for an equity value of approximately €3.5bn ($4.1bn). This move marks a strategic...
Business & Industry
UCB Acquires Candid Therapeutics in a $2 Billion-Plus Deal to Strengthen Immunology Pipeline
Belgian pharmaceutical company UCB is making a substantial move to expand its immunology pipeline, entering into a multi-billion dollar agreement to acquire Candid Therapeutics...
Business & Industry
Teva Adds Ecopipam Therapy in $700M Emalex Acquisition Deal
Teva Pharmaceuticals has entered into a definitive agreement to acquire Emalex Biosciences, strengthening its neuroscience pipeline through the addition of ecopipam, a late-stage investigational...
Business & Industry
Lilly Acquires CrossBridge to Expand Next-Gen ADC Pipeline
Eli Lilly and Company has entered into an agreement to acquire all outstanding shares of CrossBridge Bio in a transaction valued at up to...
Business & Industry
Regeneron Telix Radiopharma Deal Targets Cancer Therapies
Regeneron Pharmaceuticals has entered into a strategic agreement with Telix Pharmaceuticals to jointly develop next-generation oncology treatments, in a deal valued at up to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read